Profile
Donato Spota served as the Chief Financial Officer at Basilea Pharmaceutica AG from 2013 to 2019.
He then joined Hansa Biopharma AB as the Chief Financial Officer & Senior Vice President in 2019, a position he held until 2024.
Mr. Spota holds an MBA from Hochschule für Wirtschaft & Umwelt Nürtingen-Geislingen.
Former positions of Donato Spota
| Companies | Position | End |
|---|---|---|
| HANSA BIOPHARMA AB | Director of Finance/CFO | 28/02/2024 |
| BASILEA PHARMACEUTICA AG | Director of Finance/CFO | 10/04/2019 |
Training of Donato Spota
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Basilea Pharmaceutica AG
Basilea Pharmaceutica AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Hochschule für Wirtschaft & Umwelt Nürtingen-Geislingen
Hochschule für Wirtschaft & Umwelt Nürtingen-Geislingen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hansa Biopharma AB
Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory | Health Technology |
- Stock Market
- Insiders
- Donato Spota
















